Tuberculosis Testing

Tuberculosis Testing

Global Tuberculosis Testing Market to Reach US$2.9 Billion by 2030

The global market for Tuberculosis Testing estimated at US$2.1 Billion in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$714.5 Million by the end of the analysis period. Growth in the Chest X-Ray segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$131.8 Million While China is Forecast to Grow at 5.7% CAGR

The Tuberculosis Testing market in the U.S. is estimated at US$131.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$383.4 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Tuberculosis Testing Market - Key Trends & Drivers Summarized

Tuberculosis (TB) remains a major global health challenge, and accurate, timely testing is crucial for effective diagnosis and treatment. Tuberculosis testing involves various methods, including skin tests, blood tests, sputum tests, and molecular diagnostics. The traditional Mantoux tuberculin skin test has been widely used, but newer, more accurate tests like the interferon-gamma release assays (IGRAs) and nucleic acid amplification tests (NAATs) have been developed to improve diagnostic accuracy. These advanced tests provide quicker results and are less affected by prior BCG vaccination, which can cause false positives in skin tests.

The importance of tuberculosis testing is underscored by the high morbidity and mortality rates associated with the disease, particularly in developing countries. Early and accurate detection is critical to controlling the spread of TB and initiating appropriate treatment. Innovations in molecular diagnostics have significantly enhanced the ability to detect TB, including drug-resistant strains, enabling more targeted and effective treatment regimens. Point-of-care testing devices are also becoming more prevalent, allowing for faster diagnosis and treatment initiation in remote and resource-limited settings.

The growth in the tuberculosis testing market is driven by several factors. The increasing prevalence of TB, particularly in high-burden countries, has heightened the need for effective diagnostic solutions. Technological advancements in molecular diagnostics, such as the development of rapid, automated testing platforms, have improved the speed and accuracy of TB detection. The growing incidence of multidrug-resistant TB (MDR-TB) has also spurred the demand for advanced diagnostic tests that can identify resistance patterns and guide appropriate treatment. Additionally, global health initiatives and funding from organizations such as the WHO and the Global Fund to Fight AIDS, Tuberculosis, and Malaria are supporting the development and deployment of TB testing technologies. The integration of TB testing with broader public health efforts, such as HIV screening, further drives the market by enhancing the reach and impact of diagnostic programs.

Select Competitors (Total 55 Featured) -

• NULL

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.